Malladi Drugs to invest $300 mn in Malaysia
India’s Malladi Drugs and Pharmaceutical will invest up to $300 million over the next three to five years to set up its global “one-stop shop” in Malaysia, according to the Malaysian Biotechnology Corp (BioTech).
Malladi is an active pharma ingredient (API) manufacturer based in Chennai, India, while BioTech is the main government agency for promoting biotechnology industry in Malaysia.
BioTech Chief Executive Officer Iskandar Mizal Mahmood said here yesterday Malladi had yet to pick a site but would be encouraged to locate at one of the economic corridors in the country, in line with Malaysian Prime Minister Abdullah Ahmad Badawi’s call for those areas to be driven by biotechnology.
(Money Magazine) — John and Gina Rodrigues have always been good with numbers. John is a software engineer who manages a team at Microsoft, and Gina spent years processing 